Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that Alexandra Glucksmann, Ph.D., the Company’s Senior Vice President, Research and Business Operations, will present at the Nanotechnology Innovation Summit being organized by the Nano Science and Technology Institute (NSTI) in celebration of the 10th anniversary of the National Nanotechnology Initiative (NNI). The Summit is being held in Washington, D.C., from December 8-10, 2010.
Dr. Glucksmann has been invited to give an address in the Innovations in Life Science Technologies session of the Summit. In her address, she will highlight Cerulean’s advancement of first-in-class nanopharmaceutical drug candidates in pre-clinical and clinical development. Additionally, Dr. Glucksmann will showcase the unique potential of Cerulean’s nanopharmaceutical platform to enhance efficacy of therapeutic agents while maintaining high quality of life for patients. Dr. Glucksmann will present at 11:10 a.m. EST on Friday, December 10, 2010 in the Gaylord National Hotel and Convention Center in Washington, D.C.
The Summit is gathering leaders in nanotechnology research and development as well as in policy and finance. Other invited speakers include representatives from the White House, federal government departments and agencies, academic institutes, and industry, who will discuss the latest developments and innovations in nanotechnology. The NNI was established in 2001 with the vision of advancing leadership in nanotechnology through collaborations and dedicated funding.
Source: http://www.ceruleanrx.com/